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Abstract
The obese asthma is characterized by a more severe course. The feature of this comorbid condition is the reduced effec-
tiveness of basic therapy with inhaled corticosteroids, which prevents optimal control of symptoms, requires increasing doses and 
increases the number of exacerbations and hospitalizations. The problem of life quality (LQ) research in patients with asthma and 
obesity is highly relevant today, which made it the reason for this study.
The aim of the study was to determine the effect of obesity on LQ in patients with asthma.
Materials and methods. We selected for participating in the study 46 patients with moderate severity asthma. Examination 
of the patients included: objective examination with an anthropometric evaluation, the test of the LQ with two questionnaires: gene-
ral one – Medical Outcome Study SF-36 (MOS SF-36) and specialized Asthma Quality of Life Questionnaire (AQLQ).
Results. The increase in body mass index (BMI) in patients with asthma according to the questionnaires MOS SF-36 
and AQLQ is associated with significant reductions in viability (r = –0.33, p < 0.05), physical activity (r = –0.37, p < 0.01), social 
activity (r = –0.36, p < 0.01) and the degree of reduction of the patient’s tolerance to adverse environmental factors (r = –0.29, p < 0.05).
Conclusions. The presence of concomitant obesity in patients with asthma is associated with significant reductions in the 
parameters of physical and social activity, viability and with an increase in the subjective pain assessment (according to the question-
naire MOS SF-36) and characterized by significantly lower rates of activity, tolerance to adverse environmental factors and general 
life quality (according to the AQLQ questionnaire).
Keywords: asthma, obesity, life quality, AQLQ questionnaires, MOS SF-36 questionnaire, BMI.
DOI: 10.21303/2504-5679.2021.001842
1. Introduction
Chronic respiratory diseases consider being one of the leading in terms of prevalence, 
disability, and mortality in the world. Asthma occupies an important place among them, and re-
mains one of the most difficult medical and social problems nowadays. According to the WHO, 
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the number of patients with asthma in the world is over 330 million people and continues to grow 
steadily. The disease affects all age groups [1, 2].
In turn, the number of asthma patients in combination with obesity is growing, which is 
associated with an increase in the number of overweight people. According to various authors, 
between 36.7 and 44 % of asthma patients are obese [2, 3]. The results of epidemiological studies 
show that the presence of obesity almost 2 times increases the chances of asthma developing and, 
if previously this information was contradictory, now the accumulated data have confirmed this 
hypothesis [4]. The physiology of respiration is changed because of the excessive development of 
the adipose tissue: it leads to mechanical compression of the diaphragm, reduced lung volume, 
reduces the flexibility and strength of the respiratory muscles, and increases lung resistance [5, 6]. 
Obesity leads to systemic inflammation [7]. Adipose tissue is metabolically active and produces 
many hormone-like substances, cytokines, chemokines, which act locally and systemically, and 
also produces a large number of inflammatory mediators, which suggests an immunological link 
between obesity and asthma [8, 9]. An important role belongs to leptin, experimental studies 
proved its provision the pathogenetic mechanism of the relationship between obesity and asthma 
and supports the inflammatory process in the bronchi [10].
The obese asthma is characterized by a more severe course. The feature of this comorbid 
condition is the reduced effectiveness of basic therapy with inhaled corticosteroids, which prevents 
optimal control of symptoms, requires increasing doses and increases the number of exacerbations 
and hospitalizations [9, 11]. In this regard, GINA experts have identified a separate asthma with 
obesity phenotype [1, 11, 12]. Like any other comorbidity, the combination of asthma with obesity 
entails significant emotional, physical, and financial strains leading to the deterioration in the pa-
tient’s life quality (LQ). If earlier there was a tendency to focus exclusively on the symptoms of the 
disease, now the WHO recommends taking into account the priorities of modern medicine and aim 
not only to eliminate symptoms and normalize clinical and functional parameters, but to consider 
the improvement of the life quality as the main criterion [9, 11]. LQ is an integral indicator that 
reflects the degree of a person’s adaptation to the disease and the ability to perform the usual func-
tions corresponding to his social status. The study of LQ allows evaluation of the physical, social, 
and psychological functioning of the patient, also giving an idea of how the disease influences his 
condition. It is known from the literature that patients with a combination of obesity and bronchial 
asthma have worse LQ rates than those with normal weight, and the number of the examined people 
with LQ below average is twice as high among overweight patients [13, 14]. The problem of 
LQ research in patients with bronchial asthma and obesity is highly relevant today, which made 
it the reason for this study. 
The aim of the study – to determine the effect of obesity on LQ in patients with asthma.
2. Materials and methods
The research was conducted on the basis of the pulmonology department of the Municipal 
Non-commercial Enterprise «City Clinical Hospital No. 13» of Kharkiv City Council (Kharkiv, 
Ukraine) during 2018–2020. We examined 46 patients with moderate severity asthma, all women 
aged 35–50, and the average age was 45.2 ± 0.89 years. Diagnosis of asthma, the allocation of its 
severity was performed according to GINA recommendations [7].
The study was held according to the Helsinki Declaration adopted by the General Assembly 
of the World Medical Association (1964–2000), The Convention for the European Union on Human 
Rights and Biomedicine, relevant provisions of the WHO, and laws of Ukraine, and was approved by 
a local ethics committee of Kharkov Medical Academy of Postgraduate Education (protocol No. 1, 
from 11 Feb., 2021). All patients signed informed consent for participating in the clinical trial.
All patients underwent the general clinical examination, which included history taking 
and objective examination with an anthropometric evaluation of body mass (kg), height (m), waist 
circumference (WC, cm), hip circumference (HC, cm), followed by a body mass index calcula-
tion (BMI, WHO, kg/m2) and the relative circumference of the waist to the circumference of the 
hips (WC/HC). According to the body mass index (BMI = body weight, kg/height, m2) all pa-
tients were divided into two groups. The first group consisted of patients with BMI from 18.5 to 
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24.9 kg/m2 that is the normal weight and the second group was the patients with obesity (BMI from 
30.0 kg/m2 and more). 
All patients were treated with standard basic therapy of inhalation corticosteroids (IGCS) 
and β2-agonists of the prolonged action, according to the degree of illness severity. The groups were 
comparable in age and asthma severity. 
Exclusion criteria were: diabetes mellitus, chronic infectious, systemic, oncological and 
psychiatric diseases, and chronic heart failure with a left ventricular ejection fraction of less than 
55 %, the presence of a history of myocardial infarction, stroke and signs of ischemic heart disease, 
heart valve regurgitation more than 2 degree.
To test the LQ of patients with asthma with obesity we used two questionnaires about life 
quality: general one – Medical Outcome Study SF-36 (MOS SF-36) (Ware J. E., 1992) and specia-
lized Asthma Quality of Life Questionnaire (AQLQ) (Juniper E. F., 1995). With the questionnaire 
MOS SF-36 an assessment of LQ was carried out in points on the scales: physical activity, the role 
of physical problems in limiting vital functions, pain, general health, viability, social activity, the 
role of emotional problems in limiting vital functions, mental health. On the basis of the results of 
the AQLQ questionnaire 5 indicators of the LQ were shown: limitation of activity (activity), the se-
verity of the main symptoms of asthma (symptoms), the degree of asthma influence on the patient’s 
psycho-emotional sphere (emotions), the degree of patient’s tolerance to adverse environmental 
factors (environment), general life quality (GLQ). The survey was carried out by the questionnaire 
method based on the direct experience of the respondents. 
Parametric and non-parametric methods were used to compare the central parameters of the 
groups: Student’s t-test, Wilcoxon tests (W) and Mann-Whitney (MU). The pairwise comparison 
of groups used the criterion U – Mann-Whitney (MU), to compare the occurrence of a feature 
in the frequency analysis in groups used the Pearson test χ-square (χ2). For all statistical values, 
levels of importance were taken into account (p) 0.05; 0.01; 0.001.
3. Results
Analyzing the data of LQ when using the questionnaire SF-36 in the group of obese patients, 
a significant decrease in the parameters of physical and social activity was set, also noted an in-
crease in respondent’s subjective assessment of pain in limiting life compared to patients with nor-
mal body weight (Table 1). It is known that pain is a non-typical symptom of asthma. Even minor, 
but long-lasting physical discomfort in the form of breath shortness can be perceived by patients 
as pain. Probably, this is due to the lack of mechanisms of adaptation to this kind of feeling [7].
Table 1
Life quality indicators according to the SF-36 questionnaire (M ± m)
Indicators (in points) Group 1 n = 24 Group 2 n = 22
Physical activity 73.1 ± 2.4 59.6 ± 3.2*
The role of physical problems in limiting vital functions 53.8 ± .4.6 45.4 ± 5.5
Pain 75.0 ± 3.2 61.3 ± 3.6*
General health 47.1 ± 2.3 45.4 ± 2.2
Viability 60.5 ± 2.4 51.6 ± 3.1*
Social activity 68.4 ± 2.8 60.7 ± 2.9
The role of emotional problems in limiting life 63.2 ± 4.4 56.3 ± 4.7
Mental health 65.1 ± 2.5 59.6 ± 2.7
Note: * – reliability of differences in indicators compared with a group of patients with normal body weight
Comparison of the parameters of the general LQ in patients with normal body weight and 
obesity revealed a significant deterioration in viability, as well as a significant decrease in self- 
esteem in terms of physical and social activity.
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Analysis of AQLQ questionnaire and comparison of patient’s self-esteem clearly showed 
the impact of obesity on such areas as «general activity» and «environment»; these indicators were 
significantly higher in patients with normal body weight (Table 2). In the group of obese patients, 
the lowest was the activity rate, which scale varied from «moderate» to «absolute», there was also 
a significant decrease in the parameter «environment».
Table 2
Life quality indicators according to the AQLQ questionnaire (M ± m)





General LQ 4.2 ± 0.3 3.9 ± 0.1*
Note: * – reliability of differences in indicators compared with a group of patients with normal body weight
A correlation analysis in the group of obese patients, questionnaire SF-36, found a signif-
icant negative effect of BMI on the indicators of «viability» (r = –0.33, p < 0.05), «physical acti-
vity» (r = –0.37, p < 0.01), «social activity» (r = –0.36, p < 0.01), as well as the impact on subjective 
health assessment by the parameter «environment» (r = –0.29, p < 0.05). The obtained results clearly 
demonstrated the negative impact of obesity on LQ and the state of the psycho-emotional status 
in patients with asthma. In obese patients significantly reduced physical and psychosocial compo-
nents of health self-esteem.
4. Discussion
The study assessed the main aspects of LQ in asthma with obesity patients, and demon-
strated the influence of obesity on the general LQ and specific health. It was noted that LQ in 
asthma with obesity patients was significantly lower than in subjects with normal body weight, 
both in terms of physical functioning and social life of patients. It is consistent with previous 
studies [13, 16–17] and confirms the assumption of the obesity influence on both physical and psy-
chosocial aspects of life quality in patients with asthma.
In obese patients the physical and psychosocial components of health self-esteem were 
significantly reduced. Among the parameters relevant to physical health, the lowest were the 
parameters of physical activity and pain perception. Some authors suggest that the subjective 
sensation of pain can be explained by the influence of prolonged stress, which can lead to the 
appearance of breath shortness feeling without objective signs of increased bronchial obstruc- 
tion [12, 16].
Obesity significantly reduces the level of general and specific LQ of people with asthma, 
especially in the spheres of physical and social functions [18, 19]. All the above-mentioned allow 
considering obesity in asthma patients to be one of the main reasons for the LQ worsening [20]. 
The results of the study showed that the BMI value helps to get objective information about the 
patient’s health. Simplicity and accessibility of the LQ parameters value and the assessment of 
the health with the additional questionnaire of the asthma patients on the basis of obesity allow to 
widespread use of the data in the medical practice.
The limitations of the research. The present study was intended to investigate only the 
quality of life of asthma patients with concomitant obesity and did not include analysis of clini-
cal and laboratory parameters for these patient groups, as well as the study of patients with other 
chronic respiratory diseases and variants of comorbidity.
The further research plan to study the influence of program of complex treatment on LQ 
of obese asthma patients. 
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1. The method of questioning patients with asthma and asthma with obesity patients using 
questionnaires MOS SF-36 and AQLQ allows to study in detail the features of LQ reduction and to 
determine the contribution of each pathology separately.
2. The presence of concomitant obesity in patients with asthma when surveyed by the ques-
tionnaire MOS SF-36 is associated with significant reductions in the parameters of physical and 
social activity, viability and with an increase in the subjective pain assessment.
3. Asthma with obesity patients according to the AQLQ questionnaire in comparison with 
patients with asthma with normal body weight are characterized by significantly lower rates of 
activity, tolerance to adverse environmental factors and general life quality.
4. The increase in BMI in patients with asthma according to the questionnaires MOS SF-36 
and AQLQ is associated with significant reductions in viability (r = –0.33, p < 0.05), physical 
acti vity (r = –0.37, p < 0.01), social activity (r = –0.36, p < 0.01) and the degree of reduction of the 
patient’s tolerance to adverse environmental factors (r = –0.29, p < 0.05).
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